Citigroup Maintains Buy on Spyre Therapeutics, Raises Price Target to $97
Spyre Therapeutics Inc SYRE
$67.12
▼ -4.22%
($-2.96)
Open
$70.08
Prev Close
$70.08
Day Range
$64.67 – $70.08
52W Range
$13.93 – $78.80
Market Cap
$6.09B
Beta
3.05
EPS (TTM)
$-2.50
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2016-04-07 |
| Shares Out. | 78,780,000 |
| Website | spyre.com/ ↗ |
| Phone | 16176515940.0 |
Spyre Therapeutics Inc is a publicly traded company under the ticker symbol SYRE on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
23 analysts (2026-05-01)
📰 Latest News for SYRE
Stifel Maintains Buy on Spyre Therapeutics, Raises Price Target to $107
Spyre Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
Spyre Therapeutics, Inc. Q1 operating expenses USD 45.641 million
Spyre Therapeutics Q1 EPS $(0.74) Misses $(0.68) Estimate
Spyre Therapeutics: Q1 Earnings Snapshot
Spyre Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update